[HTML][HTML] Evaluation of persistence and healthcare utilization in patients treated with anti-seizure medications as add-on therapy: a nationwide cohort study in South …

JW Lee, JA Kim, MY Kim, SK Lee - Epilepsy & Behavior, 2022 - Elsevier
Objective To compare medication adherence and healthcare utilization among patients who
were treated with anti-seizure medications (ASMs) as first add-on to monotherapy for …

[HTML][HTML] Evaluation of persistence and healthcare utilization in patients treated with anti-seizure medications as add-on therapy: A nationwide cohort study in South …

JW Lee, JA Kim, MY Kim, SK Lee - Epilepsy & Behavior, 2022 - epilepsybehavior.com
Objective To compare medication adherence and healthcare utilization among patients who
were treated with anti-seizure medications (ASMs) as first add-on to monotherapy for …

Evaluation of persistence and healthcare utilization in patients treated with anti-seizure medications as add-on therapy: A nationwide cohort study in South Korea.

JW Lee, JA Kim, MY Kim, SK Lee - Epilepsy & Behavior: E&B, 2021 - europepmc.org
Objective To compare medication adherence and healthcare utilization among patients who
were treated with anti-seizure medications (ASMs) as first add-on to monotherapy for …

Evaluation of persistence and healthcare utilization in patients treated with anti-seizure medications as add-on therapy: A nationwide cohort study in South Korea

JW Lee, JA Kim, MY Kim, SK Lee - Epilepsy and Behavior, 2022 - snucm.elsevierpure.com
Objective: To compare medication adherence and healthcare utilization among patients who
were treated with anti-seizure medications (ASMs) as first add-on to monotherapy for …

Evaluation of persistence and healthcare utilization in patients treated with anti-seizure medications as add-on therapy: A nationwide cohort study in South Korea

JW Lee, JA Kim, MY Kim… - Epilepsy & behavior …, 2022 - pubmed.ncbi.nlm.nih.gov
Objective To compare medication adherence and healthcare utilization among patients who
were treated with anti-seizure medications (ASMs) as first add-on to monotherapy for …